Table 4 Day 1 and day 7 characteristics of participants completing the trial per protocol
Characteristics | Test Day | Placebo | APE | GE | RLE | ANE |
|---|---|---|---|---|---|---|
N (Male/Female) | Â | 17 (9/8) | 15 (7/8) | 15 (6/9) | 17 (6/11) | 17 (11/6) |
Age (years) |  | 46.7 ± 9.9 | 47.0 ± 9.3 | 52.7 ± 12.6 | 46.8 ± 8.2 | 48.4 ± 9.0 |
Body Weight (kg) | 1 | 90.8 ± 14.7 | 91.0 ± 10.4 | 88.3 ± 15.1 | 86.3 ± 13.6 | 87.9 ± 9.7 |
|  | 7 | 90.8 ± 14.7 | 91.1 ± 10.7 | 88.0 ± 15.3 | 86.3 ± 13.6 | 88.0 ± 9.6 |
BMI | 1 | 30.2 ± 3.9 | 32.0 ± 1.8 | 30.8 ± 2.9 | 30.8 ± 3.5 | 30.4 ± 3.5 |
|  | 7 | 30.1 ± 3.9 | 32.0 ± 1.9 | 30.7 ± 3.0 | 30.5 ± 3.4 | 30.4 ± 3.5 |
Total Cholesterol (mg/dL) | 1 | 206 ± 41 | 183 ± 30 | 190 ± 46 | 196 ± 34 | 200 ± 46 |
|  | 7 | 195 ± 44 | 170 ± 25 | 175 ± 35 | 191 ± 31 | 184 ± 35 |
LDL-C (mg/dL) | 1 | 135 ± 42 | 116 ± 30 | 115 ± 42 | 123 ± 34 | 133 ± 43 |
|  | 7 | 129 ± 43 | 107 ± 25 | 105 ± 29 | 117 ± 34 | 119 ± 35 |
HDL-C (mg/dL) | 1 | 50.3 ± 18.1 | 51.0 ± 17.2 | 58.7 ± 17.2 | 57.8 ± 17.7 | 50.1 ± 12.5 |
|  | 7 | 48.2 ± 19.4 | 46.3 ± 13.5 | 55.4 ± 19.8 | 54.8 ± 19.2 | 46.8 ± 11.2 |
TG (mg/dL) | 1 | 97.5 ± 39.8 | 96.7 ± 39.8 | 101.7 ± 38.7 | 102.3 ± 35.8 | 111.1 ± 46.8 |
|  | 7 | 95.8 ± 36.2 | 94.7 ± 26.4 | 90.3 ± 23.8 | 102.1 ± 57 | 103.8 ± 40.4 |